Monitor for additional insider selling or downward revisions in guidance; CEO and top commercial executive selling simultaneously may signal caution ahead of key catalysts or clinical readouts.
CYTK drugs
CYTK drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 1 $66.61entry
- T+1 · 8mo ago +0.18%α +0.09% · $66.73
- T+5 · 7mo ago −3.03%α −6.80% · $64.59
- T+20 · 7mo ago −3.96%α −13.64% · $63.97
- T+60 · 5mo ago +31.00%α +17.91% · $87.26
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two top executives at Cytokinetics, including CEO Robert Blum, sold shares in a coordinated 7-day window, generating $736,000 in total proceeds. The sales represent a modest but notable insider selling cluster, with both executives liquidating holdings at market prices.
Key Financial Metrics
Key Facts
- CEO Robert Blum sold 7,500 shares for $499,725 in open-market transaction on April 1, 2026.
- EVP Andrew Callos sold 3,639 shares for $236,535 on March 31, 2026.
- Total cluster value: $736,260 in open-market sales by C-suite executives.
- Sales represent 0.009% of Cytokinetics' $8.1B market cap, modest in scale but concerning due to executive rank.
Financial Impact
$736K in insider sales over 7 days
Risk Factors
- Perception of insider lack of confidence, especially from CEO during critical development phase
- Potential for negative market reaction if no offsetting positive news follows
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CYTK-1775075710713 |
Track record
46 reports on CYTK
6 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +8.59% at T+20 after the Sep 15, 2026 report. 9 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $53.76 Now $53.17 −1.10% settles Dec 15
- Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.13 Now $53.17 −5.27% settles Dec 14
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $56.18 Now $53.17 −5.36% settles Dec 9
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $56.18 Now $53.17 −5.36% settles Dec 9
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $55.14 Now $53.17 −3.57% settles Dec 8
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $55.14 Now $53.17 −3.57% settles Dec 8
- Nov 4, 202612d ago 8-K Bullish 6/10 No price data
- Nov 4, 202612d ago Press Release Neutral 5/10 Entry $55.55 Now $53.17 −4.28% settles Dec 4
- Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $63.60 Now $53.17 −16.40% settles Dec 3
- Nov 2, 202614d ago Press Release Neutral 3/10 Entry $62.03 Now $53.17 −14.28% settles Dec 1
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers